Citations

Clear

4610 citation(s) found for "Lu, Brian".

Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity?
Weinshenker, Brian G. , Weinshenker, Brian G

Mayo Clinic

Multiple Sclerosis Journal | September 11, 2015 | Volume: 21 | Issue: 13 | Pages: 1746-1747

10.1177/1352458515603801 | PMID 26362899 Get It

Whether or not recurrent tumefactive demyelinating lesions are a unique form of CNS demyelinating disease or part of the continuum of multiple sclerosis is a question raised by the case report on which this commentary is based. Detailed review and immunopathologic study of biopsy material may not only confirm or refute a diagnosis of demyelinating disease, but potentially uncover unique features that may assist in understanding pathophysiology and nosology of rare cases with recurrent tumefactive demyelination.
The Metastatic Spine Disease Multidisciplinary Working Group Algorithms
Robinson, Clifford G. , Meyer, Jeffrey , Gangi, Afshin , Callstrom, Matthew R. , Chao, Samuel T. , Tine, Brian Andrew Van, Bruel, Brian M., Long, Jeremiah R. , Timmerman, Robert , Buchowski, Jacob M. , Jennings, Jack W. , Wallace, Adam N, Tran, Nam D, Van Tine, Brian A, Long, Jeremiah, Timmerman, Robert D, Wallace, Adam N. , Tran, Nam , Morris, Jonathan M. , Robinson, Clifford

Mayo Clinic

The Oncologist | September 10, 2015 | Volume: 20 | Issue: 10 | Pages: 1205-1215

10.1634/theoncologist.2015-0085 | PMID 26354526 Get It

AbstractThe Metastatic Spine Disease Multidisciplinary Working Group consists of medical and radiation oncologists, surgeons, and interventional radiologists from multiple comprehensive cancer centers who have developed evidence- and expert opinion-based algorithms for managing metastatic spine disease. The purpose of these algorithms is to facilitate interdisciplinary referrals by providing physicians with straightforward recommendations regarding the use of available treatment options, including emerging modalities such as stereotactic body radiation therapy and percutaneous tumor ablation. This consensus document details the evidence supporting the Working Group algorithms and includes illustrative cases to demonstrate how the algorithms may be applied.Implications for Practice:The Metastatic Spine Disease Multidisciplinary Working Group algorithms can facilitate interdisciplinary referrals by providing physicians with straightforward recommendations regarding available treatment options, including emerging modalities such as stereotactic body radiation therapy and percutaneous tumor ablation.
Persistent Notochord in a Fetus with COL2A1 Mutation
Codsi, Elisabeth , Brost, Brian , Faksh, Arij , Volk, Amber K., Borowski, Kristi, Borowski, Kristi S

Mayo Clinic

Case Reports in Obstetrics and Gynecology | September 9, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-3

10.1155/2015/935204 | PMID 26435866 Get It

Multiple anomalies including micromelia, poor mineralization of the vertebrae, and a persistent notochord were identified on second trimester ultrasound in a fetus with aCOL2A1mutation. To our knowledge, this represents the first case of a persistent notochord associated with aCOL2A1mutation in humans. In this case report, we describe ultrasound and postmortem findings and review the pathogenesis associated with a persistent notochord.
The impact of obesity on oesophageal acid exposure time on and off proton pump inhibitor therapy
Shah, Sanaya, Lacy, Brian E. , DiBaise, John K. , Vela, Marcelo F. , Lacy, Brian E. , Crowell, Michael D.

Mayo Clinic

Alimentary Pharmacology & Therapeutics | September 8, 2015 | Volume: 42 | Issue: 9 | Pages: 1093-1100

10.1111/apt.13394 | PMID 26345151 Get It

SummaryBackgroundObesity is associated with increased oesophageal acid exposure time (AET) in patients with gastro‐oesophageal reflux (GER), and may decrease the effects of proton pump inhibitors (PPIs).AimTo evaluate the effects of increased body mass on the ability of PPI therapy to decrease AET in patients with reflux symptoms.MethodsAcid exposure time profiles collected from adult patients using wireless pH‐metry while on or off PPI therapy was retrospectively reviewed. Patients were separated into five body mass index (BMI) categories as defined by the World Health Organization. A multivariable logistic regression evaluated the association between abnormal AET and BMI groups while controlling for age, gender and pH capsule placement methods.ResultsThe study group comprised 968 patients with 336 (34.7%) studied on a PPI and 632 (65.3%) studied off PPI therapy. AET (total greater than 5.3%) was found more frequently in the overweight (67%) and obese classes (74–80%) compared to those who were normal weight (40%) while off acid‐suppressing medications (P < 0.001). No significant differences were found between these groups when studied on acid‐suppressing medications, and the proportion of patients with abnormal AET across BMI classes was similar regardless of taking a PPI either once or twice daily.ConclusionsThis is the largest study to report on the relationship between BMI and oesophageal acid exposure time in patients with GER on and off PPI therapy. We conclude that obesity is related to increased acid exposure time, but with no significant difference in acid exposure time among different weight‐based groups when taking a once or twice‐daily PPI.
Hydrolysable core crosslinked particles for receptor-mediated pH-sensitive anticancer drug delivery
Liu, Xifeng , Waletzki, Brian E., Mamo, Tewodros , Yaszemski, Michael J. , Lu, Lichun , Miller, A. Lee , Mamo, Tewodros K, Miller, Alan Lee

Mayo Clinic

New Journal of Chemistry | September 3, 2015 | Volume: 39 | Issue: 11 | Pages: 8840-8847

10.1039/c5nj01404b | PMID 27134519 Get It

An extracellular stable micelle with a folate conjugated surface, a crosslinked core and pH-sensitive hydrolysable bonds was developed for cancer targeted drug delivery.
Mechanism by Which Caloric Restriction Improves Insulin Sensitivity in Sedentary Obese Adults
Distelmaier, Klaus, Lanza, Ian R. , Irving, Brian A. , Konopka, Adam R. , Shulman, Gerald I. , Johnson, Matthew L. , Robinson, Matthew M. , Nair, K. Sreekumaran , Shulman, Gerald I , Lanza, Ian R , Konopka, Adam R

Mayo Clinic

Diabetes | August 31, 2015 | Volume: 65 | Issue: 1 | Pages: 74-84

10.2337/db15-0675 | PMID 26324180 Get It

Caloric restriction (CR) improves insulin sensitivity and reduces the incidence of diabetes in obese individuals. The underlying mechanisms whereby CR improves insulin sensitivity are not clear. We evaluated the effect of 16 weeks of CR on whole-body insulin sensitivity by pancreatic clamp before and after CR in 11 obese participants (BMI = 35 kg/m2) compared with 9 matched control subjects (BMI = 34 kg/m2). Compared with the control subjects, CR increased the glucose infusion rate needed to maintain euglycemia during hyperinsulinemia, indicating enhancement of peripheral insulin sensitivity. This improvement in insulin sensitivity was not accompanied by changes in skeletal muscle mitochondrial oxidative capacity or oxidant emissions, nor were there changes in skeletal muscle ceramide, diacylglycerol, or amino acid metabolite levels. However, CR lowered insulin-stimulated thioredoxin-interacting protein (TXNIP) levels and enhanced nonoxidative glucose disposal. These results support a role for TXNIP in mediating the improvement in peripheral insulin sensitivity after CR.
Posterior reversible encephalopathy syndrome is not associated with mutations in aquaporin-4
Matiello, Marcelo , Muralidharan, Rajanandini , Sun, David, Weinshenker, Brian G. , Rabinstein, Alejandro A. , Weinshenker, Brian G

Mayo Clinic

Neurology Genetics | August 27, 2015 | Volume: 1 | Issue: 2 | Pages: No page available

10.1212/nxg.0000000000000013 | PMID 27066556 Get It

Genome-Wide Association Study of Prostate Cancer–Specific Survival
Szulkin, Robert , Whitington, Thomas, Aly, Markus , Grönberg, Henrik , Eeles, Rosalind A. , Easton, Douglas F. , Olama, Ali Amin Al , Benlloch, Sara, Muir, Kenneth , Giles, Graham G. , Southey, Melissa C. , FitzGerald, Liesel M. , Henderson, Brian E., Schumacher, Fredrick R. , Haiman, Christopher A. , Sipeky, Csilla , Tammela, Teuvo L.J. , Nordestgaard, Børge G. , Travis, Ruth C. , Neal, David E. , Donovan, Jenny , Hamdy, Freddie C. , Pashayan, Nora , Stanford, Janet L. , Thibodeau, Stephen N. , McDonnell, Shannon K. , Schaid, Daniel J. , Maier, Christiane, Vogel, Walther , Luedeke, Manuel, Herkommer, Kathleen , Kibel, Adam S. , Lubiński, Jan , Kluźniak, Wojciech , Cannon‐Albright, Lisa , Brenner, Hermann , Herrmann, Volker, Holleczek, Bernd , Sellers, Thomas A. , Lim, Hui-Yi, Kaneva, Radka , Mitev, Vanio , Teixeira, Manuel R. , Paulo, Paula , Maia, Sofia , Pandha, Hardev , Michael, Agnieszka , Batra, Jyotsna , Clements, Judith A. , BioResource, on behalf of the Australian Prostate Cancer, Albanes, Demetrius, Andriole, Gerald L. , Berndt, Sonja I., Gapstur, Susan M. , Giovannucci, Edward L. , Ma, Jing , Mondul, Alison M. , Stampfer, Meir J. , Stevens, Victoria L. , Weinstein, Stephanie J. , Trichopoulou, Antonia , Bueno-de-Mesquita, Bas H., Tjønneland, Anne , Cox, David G. , Mæhle, Lovise, Schleutker, Johanna , Lindström, Sara , Karlsson, Robert , Kote‐Jarai, Zsofia , Key, Tim , Pharoah, Paul D.P. , Khaw, Kay‐Tee , Cybulski, Cezary , Park, Jong Y. , Slavov, Chavdar , Spurdle, Amanda B. , Kierzek, Andrzej , BioResource, on behalf of the Australian Prostate Cancer, Berndt, Sonja I. , Chanock, Stephen Jacob , Hunter, David J. , Kraft, Peter , Marchand, Loı̈c Le , Penney, Kathryn , Wiklund, Fredrik E. , Giles, Graham G , Teixeira, Manuel R , Eeles, Rosalind A , Southey, Melissa C , Tjønneland, Anne , Donovan, Jenny L , Muir, Kenneth , Schleutker, Johanna , Travis, Ruth C , Pashayan, Nora , Cannon-Albright, Lisa A , Michael, Agnieszka , Brenner, Hermann , Batra, Jyotsna , Clements, Judith , Lubinski, Jan , McDonnell, Shannon K

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | August 25, 2015 | Volume: 24 | Issue: 11 | Pages: 1796-1800

10.1158/1055-9965.epi-15-0543 | PMID 26307654 Get It

Abstract Background: Unnecessary intervention and overtreatment of indolent disease are common challenges in clinical management of prostate cancer. Improved tools to distinguish lethal from indolent disease are critical. Methods: We performed a genome-wide survival analysis of cause-specific death in 24,023 prostate cancer patients (3,513 disease-specific deaths) from the PRACTICAL and BPC3 consortia. Top findings were assessed for replication in a Norwegian cohort (CONOR). Results: We observed no significant association between genetic variants and prostate cancer survival. Conclusions: Common genetic variants with large impact on prostate cancer survival were not observed in this study. Impact: Future studies should be designed for identification of rare variants with large effect sizes or common variants with small effect sizes. Cancer Epidemiol Biomarkers Prev; 24(11); 1796–800. ©2015 AACR.
Long‐term quality of life outcomes and retreatment rates after robotic sacrocolpopexy
Linder, Brian J. , Chow, George K. , Elliott, Daniel S. , Linder, Brian J

Mayo Clinic

International Journal of Urology | August 24, 2015 | Volume: 22 | Issue: 12 | Pages: 1155-1158

10.1111/iju.12900 | PMID 26300382 Get It

ObjectiveTo evaluate the long‐term outcomes and potential predictors of treatment failure after robotic sacrocolpopexy.MethodsWe identified 70 consecutive patients from 2002 to 2012 with symptomatic post‐hysterectomy vaginal vault prolapse that underwent robotic sacrocolpopexy. Multiple clinical and surgical variables were evaluated for potential association with treatment failure, which was defined as any repeat operation for recurrent prolapse or mesh‐related complications.ResultsThe median age at surgery was 67 years (interquartile range 59–74 years) and median follow up was 72 months (interquartile range 39–114 months). Overall, six out of 70 patients (8.6%) underwent a total of six secondary surgeries, including four for recurrent prolapse (two anterior repairs, one posterior repair, one apical) and two mesh complications. No patient‐related factors were associated with the risk of repeat surgery: age (P = 0.45), diabetes mellitus (P = 0.24), tobacco use (P = 0.61) or prior prolapse surgery (P = 0.1) on univariate analysis. Freedom from repeat prolapse surgery or surgery for mesh complication was 98% at 1 year, 95% at 3 years and 90% at 6 years. At last follow up, 80% of patients reported that they would or probably would recommend robotic sacrocolpopexy to a family member or friend.ConclusionsRobotic sacrocolpopexy is associated with excellent long‐term outcomes. Recognition of long‐term success is important for preoperative patient counseling.
Aberrant Gene Regulation in Obstetric, Gynecologic, and Reproductive Diseases
Jiang, Shi‐Wen , Brost, Brian , Zhang, Dan , Ren, Chune

Mayo Clinic

BioMed Research International | August 23, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-2

10.1155/2015/187691 | PMID 26366409 Get It